Helixim

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Helixim

Quick Facts

Property Description
Active ingredient Cefixime
Form Tablets, Capsules, Oral Suspension
Pharmacological class Third-generation Cephalosporin Antibiotic
Common use Resolution of bacterial infections
Origin Synthetic

What Type of Medicine is Helixim?

Helixim is a prescription-only medicine containing the active ingredient Cefixime, which is chemically defined as a synthetic, third-generation cephalosporin antibiotic. This medication belongs to the broader beta-lactam family of antimicrobial agents, clinically recognized for their precise mechanism against susceptible bacteria. Cefixime's classification as a third-generation cephalosporin provides a broader spectrum of activity compared to earlier generations, enhancing its ability to target diverse types of bacteria in patients.


Composition, Origin, and Available Forms

The therapeutic effect of Helixim is derived solely from the active ingredient Cefixime, establishing it as a single-ingredient product. This medicine is administered Oral (Systemic) and is available in forms such as Tablets and Capsules, as well as a powder for Oral Suspension. The suspension form is particularly practical for Pediatric Patients (Children) and others who may have difficulty swallowing pills. The Cefixime molecule is a synthetic structure.


What is the General Purpose of Taking Cefixime?

The primary purpose of Cefixime is to help the body effectively resolve bacterial infections caused by susceptible microorganisms. Cefixime functions through Bactericidal Action, meaning it actively kills the targeted bacteria. This mechanism disrupts the bacteria’s vital process of cell wall synthesis, a destructive process that ensures the pathogen cannot survive or proliferate. This action is critical for clearing the bacterial load and is the basis for the medicine's role as an effective antimicrobial agent.

What side effects are possible with Helixim?

Possible Side Effects and Safety Information

This section describes the officially documented adverse reactions and safety characteristics of medicines containing Cefixime, as strictly classified and published by government regulatory authorities.


Regulatory Safety Profile

Adverse reactions are formally categorized by frequency and grouped according to the affected System-Organ-Classes (SOC) defined in official labeling. The most frequently reported adverse reactions include gastrointestinal disturbances such as diarrhea, nausea, loose stools, and abdominal pain. These effects are generally classified as Common or Most Common in clinical data.

Effects on other systems, such as the Hemic and Lymphatic System (e.g., changes in blood cell counts) and the Hepatic System (e.g., transient elevations in liver enzymes), are also documented but occur with a lower incidence.


Serious Adverse Reactions

Official labeling highlights several rare but clinically significant adverse reactions. These include severe Hypersensitivity Reactions (e.g., Anaphylaxis), which can be fatal. Additionally, the medicine is associated with a risk of Clostridioides difficile-Associated Diarrhea (CDAD) and severe skin conditions classified as Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).


Safety Considerations and Restrictions

Use of Cefixime is contraindicated in individuals with a known hypersensitivity or allergy to the cephalosporin class of antibiotics. Population-specific safety notes are also included, advising on the need for monitoring and potential dose consideration for patients with renal impairment. The onset of symptoms for conditions like CDAD may occur during or after therapy is completed. The safety profile also includes a warning that concomitant use with anticoagulants may affect prothrombin time.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Cefixime (Helixim) is officially documented in regulatory information primarily as a risk of Central Nervous System (CNS) toxicity.

Overdose Scope

Property Documented Regulatory Information
Documented Overdose Presentations Encephalopathy (brain dysfunction), convulsions (seizures), confusion, impairment of consciousness, and movement disorders are noted regulatory manifestations.
Physiological Systems Affected The CNS is the primary system affected in severe overdose; Acute Renal Failure is a potential risk associated with the cephalosporin class.
Population-specific Overdose Notes The risk of severe CNS effects, including encephalopathy and seizures, is specifically increased in patients with pre-existing renal impairment.
Emergency-response statements No specific antidote exists for Cefixime overdose. Treatment should be symptomatic and supportive, and gastric lavage may be indicated.

When Immediate Medical Help is Required

Seek immediate medical attention or call the poison control center immediately in the event of suspected overdose. The need to immediately call emergency services is mandated if the person has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened, as these are signs of severe, life-threatening CNS effects documented in official labeling.


The regulatory profile emphasizes the need for urgent response due to the potential for severe, documented neurological outcomes like seizures and encephalopathy. Since official documents state there is no specific antidote, the mandated course of action is immediate supportive care and hospital monitoring.

Therapeutic Uses of Helixim

Quick Facts: What Helixim Treats

  • Respiratory Support: Intended for the management of bacterial infections affecting the respiratory system, including the lungs and throat.
  • Urinary Tract: Utilized in the treatment of bacterial infections within the urinary tract.
  • Ear/Nasal Sinus: May contribute to the resolution of bacterial infections impacting the ear and nasal sinuses.
  • Sexually Transmitted Diseases: Used as part of a therapeutic regimen for certain sexually transmitted bacterial infections.

What Helixim Treats: Main Uses and Benefits

Helixim is a compound that is authorized for prescription to address certain bacterial infections in the body. Its primary role involves supporting the resolution of infections in several major therapeutic domains, as determined by a healthcare professional.

This medication is specifically indicated for conditions arising from susceptible bacteria, which commonly include infections in the respiratory tract, such as those affecting the lungs and throat. It is also a considered option for managing urinary tract infections (UTIs) and is utilized to help clear bacterial infections of the ear and nasal sinuses.

Additionally, Helixim plays a therapeutic part in the treatment of certain sexually transmitted diseases (STDs) caused by susceptible organisms. The benefit of this treatment is its designated function in inhibiting the proliferation of pathogenic bacteria, thereby assisting the body in overcoming the infection.

It is important to note that this compound is intended only for bacterial infections and will not impact viral conditions like the common cold or flu. Treatment should be continued for the duration advised by a prescribing clinician to achieve the intended therapeutic effect.

Eligibility and Restrictions for Use

Population Eligibility for Helixim

Helixim (Cefixime) is approved for use in adult patients and pediatric patients six months of age and older. The safety and effectiveness of the medicine have not been established in infants younger than six months, according to regulatory documents. Older adults may typically use the standard adult dose, provided their kidney function is normal.


Absolute Prohibitions (Contraindications)

The medicine is strictly contraindicated and must not be used by individuals with a known allergy or hypersensitivity to the active ingredient Cefixime or to any antibiotic belonging to the cephalosporin class.


Conditional and Restricted Use

Use of Helixim is conditional in several populations. Patients with impaired renal function (Creatinine Clearance < 60 mL/min) are eligible, but require a prescribed adjustment to the standard regimen. Use requires caution for individuals with a history of penicillin allergy due to the potential for cross-sensitivity, and for those with a history of colitis or severe gastrointestinal disease.

Regarding pregnancy, the medicine should only be used if it is clearly needed. For breastfeeding, consideration is given to temporarily discontinuing nursing during the course of treatment. The chewable tablet formulation is restricted for patients with Phenylketonuria (PKU) as it contains phenylalanine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Helixim (Cefixime) has several officially documented interaction patterns that are described in government regulatory documents. These interactions primarily involve changes to drug plasma exposure and pharmacodynamic effects.

Documented Exposure and Pharmacodynamic Interactions

Interacting Substance/Class Official Regulatory Outcome
Warfarin and Anticoagulants Co-administration may increase prothrombin time, which may lead to bleeding.
Carbamazepine Post-marketing reports document elevated Carbamazepine plasma concentrations.
Probenecid Reduces Cefixime total clearance, resulting in increased Cefixime plasma levels.
Live Bacterial Vaccines May decrease the therapeutic efficacy of vaccines such as BCG, Typhoid, and Cholera.

Interaction-Related Constraints

Coagulation effects, such as the increase in prothrombin time with anticoagulants, are of particular concern and require specific consideration in patients with pre-existing renal impairment, hepatic dysfunction, or poor nutritional state. The administration of the Cefixime capsule formulation with food reduces Cefixime systemic exposure, specifically lowering the AUC and Cmax. Additionally, Cefixime causes false-positive reactions for urine glucose when copper reduction tests are utilized, necessitating the use of enzymatic methods for testing.

Mechanism of Action

Targeted Inhibition of Bacterial Cell Wall Synthesis

Helixim exerts a bactericidal effect by directly and irreversibly inhibiting Penicillin-Binding Proteins (PBPs), which are bacterial enzymes necessary for synthesizing the cell wall's rigid structure. By blocking the final cross-linking step of peptidoglycan, the drug causes the formation of a structurally defective cellular envelope. The resulting failure to maintain osmotic balance leads to cell lysis, which is the physiological event of the bacterium rupturing and dying.


Mechanisms for Sustained Pathogen Clearance

The drug's molecular structure provides stability against many common bacterial beta-lactamase enzymes. This feature results in the beta-lactam ring resisting hydrolysis, which facilitates the molecule's access to its PBP targets despite the presence of many beta-lactamase enzymes. This stability contributes to the mechanism's action of reducing the viable pathogen burden within affected physiological systems.


Constraints on Mechanistic Efficacy

The mechanism is entirely dependent on the presence of the bacterial peptidoglycan cell wall. These intrinsic limitations define the scope of the drug's activity to only susceptible bacteria. Efficacy is further constrained by bacterial mechanisms that modify PBP affinity or produce specific, high-level Extended-Spectrum beta-Lactamases (ESBLs). Consequently, the mechanism is ineffective against non-bacterial pathogens (e.g., viruses or fungi) which lack the essential cellular target.

Dosage and Administration Information

The administration of Helixim (Cefixime) is governed by official protocols that define the route, dose, frequency, and duration of use. The medicine is strictly approved for Oral administration. The standard adult daily dose is 400 mg. This may be administered as a single dose once daily, or as two divided 200 mg doses every 12 hours. For certain uncomplicated infections, a single 400 mg oral dose is specified.

Administration Protocol Official Labeled Instruction
Intake Condition Tablets and capsules are taken without regard to food.
Preparation The oral suspension must be shaken well before measuring. Chewable tablets must be chewed or crushed.
Duration Treatment duration varies by infection, but must be continued for a minimum of 10 days for infections caused by Streptococcus pyogenes.
Renal Adjustment Dosage modification is required for patients with severe renal impairment (Creatinine Clearance le 20 mL/min), typically to 200 mg once daily.
Pediatric Use For children 6 months and older, dosing is based on body weight, typically 8 mg/kg/day of the oral suspension.

These official guidelines establish the precise parameters for the proper usage of Cefixime, ensuring correct preparation and defining necessary dose modifications for specific patient populations. The product's different oral forms are not interchangeable without expert guidance due to variations in bioavailability.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Atorvastatin


Evidence for use in Hypercholesterolemia

Large-scale randomized controlled trials (RCTs) and meta-analyses were studied to explore patterns observed on cholesterol levels in adults. Researchers monitored outcomes primarily related to lipid panel components (e.g., LDL-C, total cholesterol, triglycerides) and the occurrence of major cardiovascular events (MACE). Findings describe patterns where studies reported measurements of changes in these lipid components. Some long-term trials described patterns such as fewer MACE occurrences in the group receiving this agent compared to control groups. What remains uncertain is the long-term profile in very specific rare subtypes, and variability exists in reported outcomes across diverse patient groups.


Evidence for use in Primary and Secondary Prevention

Research examined the agent in both primary prevention (adults at high risk without prior events) and secondary prevention (patients with established CVD). RCTs tracked the occurrence of first-time heart attacks or strokes and the recurrence of MACE. For both settings, trials described measurements of a difference in the frequency of cardiovascular events among individuals receiving the agent compared to placebo or control. However, evidence is limited for individuals at very low risk, and the heterogeneity of results applies only to the populations studied.


Long-term Patterns and Special Populations

Research examined the agent in several special patient populations, including older adults and children with familial hypercholesterolemia. For children with this condition, changes in lipid levels were observed. The patterns noted in the studies related to cardiovascular event frequency were tracked over several years. However, limited information for long-term outcomes exists that goes well beyond the typical follow-up durations of the longest controlled trials. Certainty remains low in areas concerning the full implications for certain complex co-morbidities, and data for very elderly patients remain insufficient.

Frequently Asked Questions (FAQ)

Common questions about Helixim (FAQ)

Q: How quickly should I expect Helixim to start working?

The drug's mechanism of action is bactericidal, meaning it works by immediately initiating bactericidal action against susceptible bacteria. Official product information indicates that the peak concentration of the medicine in the bloodstream is typically reached about 4 hours after you take a dose. However, the time required to see the full clinical benefit (feeling better) depends on the specific infection being treated and may require completing the entire prescribed course.

Q: What happens if I miss a dose of Helixim?

If a dose is missed, regulatory information suggests taking it as soon as you remember. If it is almost time for your next scheduled dose, official guidance indicates skipping the missed dose and returning to the regular schedule. Official instructions caution against taking two doses to make up for a missed one.

Q: Can Helixim be taken with blood pressure medication?

Official labeling lists specific drug-drug interaction warnings for certain medicines, such as blood thinners like Warfarin, but does not address all blood pressure medications as a single class. It is important for patients to inform their healthcare provider of all medicines being taken.

Q: Are there any foods or drinks I need to avoid while taking Helixim?

Official drug labels do not contain a specific contraindication or warning to avoid alcohol. The drug may be taken without regard to food, though taking the capsule form with food may lower the amount of medicine absorbed into the body.

Q: Is it normal to feel tired after starting Helixim?

Tiredness, weakness, and drowsiness have all been reported as adverse reactions listed in the official drug information.

Q: Will Helixim affect my sleep?

Drowsiness is a reported adverse reaction. Additionally, some regulatory documents list increased night-time urination as a possible side effect.

Q: How does Helixim leave the body?

According to the official pharmacokinetics data, the medicine is not significantly broken down (metabolized) by the body. About 50% of the absorbed dose is excreted unchanged, primarily through the urine.

Q: Are there long-term side effects from using Helixim?

While this is generally a short-course medicine, using it for prolonged periods may lead to superinfections. Also, a serious adverse reaction, diarrhea caused by C. difficile, may occur even up to two months or more after treatment is completed.

Q: Can I drive a car while taking Helixim?

Some reported side effects, such as dizziness, headache, and confusion, may impair the ability to operate machinery or drive a vehicle. Official information advises exercising caution until the patient is aware of the medicine's effects.

Q: Does Helixim cause weight changes?

Official regulatory data reports both rapid weight gain and unusual weight loss as potential adverse effects, though the frequency of these reactions (how often they occur) has not been widely reported in clinical studies.

Q: Can I stop taking Helixim as soon as I feel better?

Official guidance emphasizes the importance of completing the full course of treatment exactly as prescribed. Completing the course is important to support the clearance of the infection and to help reduce the possibility of developing drug-resistant bacteria.

Q: Is Helixim used to treat [Specific condition people often mistakenly associate with the drug]?

The official labeling specifies that the drug is indicated for certain bacterial infections only. These include specific infections of the middle ear (otitis media), tonsillitis, the throat, and the urinary tract. It is ineffective against non-bacterial infections, such as those caused by viruses or fungi.

Q: How long does Helixim stay in your system?

The elimination half-life for the drug is typically reported to be between 3 and 4 hours. This means it takes 3 to 4 hours for the amount of medicine in the blood to be reduced by half. Most of the absorbed drug is fully cleared from the system within 24 hours.

Q: Does Helixim affect birth control pills?

Official drug information states that this medicine may reduce the effectiveness of some oral contraceptives (birth control pills) by altering the natural bacteria in the digestive tract. Official guidance suggests that individuals using hormonal contraceptives seek advice from their healthcare provider regarding the need for alternate or additional barrier methods.

Q: Can I take Helixim if I have a liver condition?

Official use information indicates that patients with severe liver conditions, such as cirrhosis, may experience a prolonged period for the medicine to be cleared from the body. However, a dose adjustment is generally not necessary. Individuals with any liver disease are advised to inform their prescribing healthcare provider.

Q: What research studies are available about Helixim?

The official FDA label and similar regulatory documents contain a section that summarizes the clinical studies and evidence that were used to support the drug's approval for its specific indications.

Q: Is Helixim safe for older people?

Studies summarized in official documents indicate that older adults can typically receive the standard adult dose, but caution is advised, and monitoring for kidney function is important, as kidney function often decreases with age.

Q: Does Helixim require any special monitoring or blood tests?

Official labeling advises that monitoring may be required for certain patients, specifically those with impaired vitamin K synthesis or those receiving dialysis. For these individuals, regulatory guidelines suggest monitoring factors like prothrombin time (related to blood clotting).

Q: Can Helixim be crushed or split?

Regulatory information specifies that the capsule form should be swallowed whole and should not be cut, broken, or chewed. However, the 400 mg tablet form may be split in half. Chewable tablets, when available, are explicitly intended to be chewed or crushed before swallowing.

Q: What if I take too much Helixim?

Official regulatory guidelines advise immediately seeking emergency medical help or contacting a Poison Control Center if an overdose is suspected. Regulatory warnings note that an overdose, especially in patients with kidney problems, may increase the risk of neurological effects like seizures.

Q: Does the time of day I take Helixim matter?

The medicine can be taken once daily or split into two doses (every 12 hours) and may be taken with or without food. No specific time of day is required, but consistency in dosing schedule is important.

Q: What happens if I take Helixim for longer than prescribed?

Taking the medicine for longer than the prescribed duration may lead to superinfections, such as fungal or yeast infections.

Q: Is it normal to experience dizziness when starting Helixim?

Dizziness has been reported as an adverse reaction in clinical studies and in post-marketing reports.

Q: What is the mechanism by which Helixim can cause [Common but serious listed side effect]?

Regulatory warnings indicate that beta-lactam antibiotics, the class to which this drug belongs, may predispose patients to rare but serious neurological side effects like seizures and encephalopathy (a general brain disease). This risk is particularly noted in cases of overdose or severe kidney impairment.

Q: How long until the benefits of Helixim are fully realized?

The medicine is a bactericidal antibiotic that acts quickly against susceptible bacteria. A full therapeutic course of treatment often requires a minimum of 10 days for certain infections.

How should Helixim be stored and disposed of?

How to Store and Dispose of Helixim?

Helixim requires strict control over its storage conditions to maintain efficacy. Official regulatory labeling mandates storing the medicine in a refrigerator between 2°C and 8°C (36°F and 46°F), and it must not be frozen. To protect the contents from light, keep the product in its original carton until the time of use.

After reconstitution or dilution, the product has limited stability and should be used immediately or stored at 2 C to 8 C and used within 24 hours. When handling the medicine, it is important not to shake the vial. For safety, this medicine must be kept out of the sight and reach of children.

Proper disposal is required for patient safety and environmental protection. All used needles and syringes must be placed immediately into a dedicated, puncture-resistant sharps disposal container. Unused medication or waste materials should be disposed of in accordance with local regulatory requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Helixim found in:

A-Z Index: